Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

PLSE vs UFPT: stock comparison and AI forecast

Pulse Biosciences, Inc. (PLSE) and Ufp Technologies Inc (UFPT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Surgical & Medical Instruments & Apparatus

PLSE Pulse Biosciences, Inc.

Price
$52.90 +164.1% · 6M
Market Cap
$3.77B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Surgical & Medical Instruments & Apparatus

UFPT Ufp Technologies Inc

Price
$283.97 +47.5% · 6M
Market Cap
$2.20B
P/E Ratio
30.7x
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-04 → 2026-11-03

Six-month price performance

Closing prices rebased to 100 at the start of the window.

90135180225270
PLSE +164.1% UFPT +47.5%
PLSE · UFPT

Key facts

  • PLSE is 1.7 times larger than UFPT by market capitalization ($3.77B against $2.20B).
  • Over the last six months PLSE returned +164.1% and UFPT +47.5%.
  • UFPT turns 11.4% of its revenue into net income, against -6755.8% for PLSE.
  • UFPT carries 0.47 times debt per unit of equity, against 0.16 times for PLSE.
  • Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricPLSEUFPT
Market Cap$3.77B$2.20B
P/E Ratio–30.68x
P/B Ratio37.92x4.76x
EPS–$9.25
Book Value/Share$1.40$59.70
Revenue/Share$0.02$81.55
FCF/Share$-0.86–

Profitability & Margins

MetricPLSEUFPT
ROE-80.5%15.6%
ROA-69.3%10.6%
ROIC-79.4%16.0%
Gross Margin-2.4%28.5%
Operating Margin-7007.8%15.2%
Net Margin-6755.8%11.4%
EBT Margin5429.6%14.0%
Tax Rate0.0%18.4%

Financial Health

MetricPLSEUFPT
Current Ratio9.63x3.00x
Quick Ratio9.61x1.72x
D/E Ratio0.16x0.47x
Financial Leverage1.16x1.47x
Interest Coverage-8308.5x16.4x
Working Capital$95M$157M

Cash Flow

MetricPLSEUFPT
Operating Cash Flow-$61M$72M
Free Cash Flow-$61M–
Capital Spending-$290K–
OCF Growth YoY–-14.1%
FCF/Sales-5180.4%–
CapEx/Sales24.5%–

Operational Efficiency

MetricPLSEUFPT
Asset Turnover0.01x0.93x
Receivables Turnover9.7x5.6x
Inventory Turnover5.0x4.5x
Fixed Assets Turnover1.1x8.2x
Days Sales Outstanding38 days65 days
Days Inventory73 days81 days
Payables Period875 days27 days
Cash Conversion Cycle-764 days120 days

Income Statement

MetricPLSEUFPT
Total Revenue$1M$632M
Operating Income-$83M$96M
Net Income-$80M$72M
R&D Expense$52M–
SG&A Expense$47M$84M
Cost of Goods Sold$1M$452M

Dividend & Shareholder Information

MetricPLSEUFPT
Shares Outstanding71M8M
Net Income Growth–7.7%
EPS Growth–7.4%
FAQ

PLSE vs UFPT: stock comparison and AI forecast

Which is bigger, PLSE or UFPT?

PLSE is 1.7 times larger than UFPT by market capitalization ($3.77B against $2.20B).

Which stock performed better over the last six months, PLSE or UFPT?

Over the last six months PLSE returned +164.1% and UFPT +47.5%.

Which one does Intratio's AI model rank higher, PLSE or UFPT?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.